William Blair analyst Matt Phipps reiterated an Outperform rating on Insmed (NASDAQ: INSM)The analyst commented, "This morning, Insmed released top-line ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments